Go Pro
→ The cat is out the bag (From Porter & Company) (Ad)tc pixel Free YTEN Stock Alerts

Yield10 Bioscience (YTEN) Competitors

Yield10 Bioscience logo
Compare

YTEN vs. ORIS, EDBL, AAGRW, CHSCP, and EDBLW

Should you buy Yield10 Bioscience stock or one of its competitors? Yield10 Bioscience's main competitors and comparable companies include Oriental Rise (ORIS), Edible Garden (EDBL), African Agriculture (AAGRW), CHS (CHSCP), and Edible Garden (EDBLW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "agricultural products & services" industry.

How does Yield10 Bioscience compare to Oriental Rise?

Oriental Rise (NASDAQ:ORIS) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Oriental Rise has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market. Comparatively, Yield10 Bioscience has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

In the previous week, Oriental Rise's average media sentiment score of 0.00 equaled Yield10 Bioscience'saverage media sentiment score.

Company Overall Sentiment
Oriental Rise Neutral
Yield10 Bioscience Neutral

4.9% of Yield10 Bioscience shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Given Yield10 Bioscience's higher possible upside, analysts plainly believe Yield10 Bioscience is more favorable than Oriental Rise.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oriental Rise
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Yield10 Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
Oriental RiseN/A N/A N/A
Yield10 Bioscience N/A N/A -296.08%

Oriental Rise has higher revenue and earnings than Yield10 Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oriental Rise$12.22M0.04$680KN/AN/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

Summary

Oriental Rise beats Yield10 Bioscience on 5 of the 8 factors compared between the two stocks.

How does Yield10 Bioscience compare to Edible Garden?

Edible Garden (NASDAQ:EDBL) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Edible Garden currently has a consensus price target of $45.00, suggesting a potential upside of 2,594.61%. Given Edible Garden's stronger consensus rating and higher possible upside, research analysts clearly believe Edible Garden is more favorable than Yield10 Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edible Garden
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Yield10 Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Yield10 Bioscience has a net margin of 0.00% compared to Edible Garden's net margin of -131.59%.

Company Net Margins Return on Equity Return on Assets
Edible Garden-131.59% N/A -88.36%
Yield10 Bioscience N/A N/A -296.08%

Edible Garden has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market. Comparatively, Yield10 Bioscience has a beta of 1.48, indicating that its share price is 48% more volatile than the broader market.

13.0% of Edible Garden shares are held by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are held by institutional investors. 0.8% of Edible Garden shares are held by insiders. Comparatively, 6.1% of Yield10 Bioscience shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Yield10 Bioscience has lower revenue, but higher earnings than Edible Garden. Edible Garden is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edible Garden$12.81M0.02-$17.33M-$4.94 thousandN/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

In the previous week, Edible Garden had 9 more articles in the media than Yield10 Bioscience. MarketBeat recorded 9 mentions for Edible Garden and 0 mentions for Yield10 Bioscience. Edible Garden's average media sentiment score of 0.31 beat Yield10 Bioscience's score of 0.00 indicating that Edible Garden is being referred to more favorably in the media.

Company Overall Sentiment
Edible Garden Neutral
Yield10 Bioscience Neutral

Summary

Edible Garden beats Yield10 Bioscience on 10 of the 14 factors compared between the two stocks.

How does Yield10 Bioscience compare to African Agriculture?

Yield10 Bioscience (NASDAQ:YTEN) and African Agriculture (NASDAQ:AAGRW) are both consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Yield10 BioscienceN/A N/A -296.08%
African Agriculture N/A N/A N/A

4.9% of Yield10 Bioscience shares are held by institutional investors. 6.1% of Yield10 Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

African Agriculture has higher revenue and earnings than Yield10 Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A
African Agriculture$1.75MN/AN/AN/AN/A

In the previous week, African Agriculture had 2 more articles in the media than Yield10 Bioscience. MarketBeat recorded 2 mentions for African Agriculture and 0 mentions for Yield10 Bioscience. African Agriculture's average media sentiment score of 0.46 beat Yield10 Bioscience's score of 0.00 indicating that African Agriculture is being referred to more favorably in the news media.

Company Overall Sentiment
Yield10 Bioscience Neutral
African Agriculture Neutral

Summary

African Agriculture beats Yield10 Bioscience on 4 of the 6 factors compared between the two stocks.

How does Yield10 Bioscience compare to CHS?

CHS (NASDAQ:CHSCP) and Yield10 Bioscience (NASDAQ:YTEN) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

In the previous week, CHS had 1 more articles in the media than Yield10 Bioscience. MarketBeat recorded 1 mentions for CHS and 0 mentions for Yield10 Bioscience. CHS's average media sentiment score of 1.89 beat Yield10 Bioscience's score of 0.00 indicating that CHS is being referred to more favorably in the media.

Company Overall Sentiment
CHS Very Positive
Yield10 Bioscience Neutral

CHS has higher revenue and earnings than Yield10 Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CHS$35.46BN/A$597.92MN/AN/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

4.9% of Yield10 Bioscience shares are held by institutional investors. 2.3% of CHS shares are held by insiders. Comparatively, 6.1% of Yield10 Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

CHS has a net margin of 1.54% compared to Yield10 Bioscience's net margin of 0.00%. CHS's return on equity of 6.51% beat Yield10 Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
CHS1.54% 6.51% 2.84%
Yield10 Bioscience N/A N/A -296.08%

CHS has a beta of 0.26, suggesting that its stock price is 74% less volatile than the broader market. Comparatively, Yield10 Bioscience has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market.

Summary

CHS beats Yield10 Bioscience on 7 of the 10 factors compared between the two stocks.

How does Yield10 Bioscience compare to Edible Garden?

Edible Garden (NASDAQ:EDBLW) and Yield10 Bioscience (NASDAQ:YTEN) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

In the previous week, Edible Garden had 4 more articles in the media than Yield10 Bioscience. MarketBeat recorded 4 mentions for Edible Garden and 0 mentions for Yield10 Bioscience. Edible Garden's average media sentiment score of 0.72 beat Yield10 Bioscience's score of 0.00 indicating that Edible Garden is being referred to more favorably in the media.

Company Overall Sentiment
Edible Garden Positive
Yield10 Bioscience Neutral

Edible Garden has higher revenue and earnings than Yield10 Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edible Garden$13.43MN/AN/AN/AN/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

Company Net Margins Return on Equity Return on Assets
Edible GardenN/A N/A N/A
Yield10 Bioscience N/A N/A -296.08%

4.9% of Yield10 Bioscience shares are held by institutional investors. 6.1% of Yield10 Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Edible Garden beats Yield10 Bioscience on 4 of the 6 factors compared between the two stocks.

Get Yield10 Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding YTEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

YTEN vs. The Competition

Export
MetricYield10 BioscienceFood Products IndustryConsumer Staples SectorNASDAQ Exchange
Market Cap$257K$5.83B$16.14B$13.04B
Dividend YieldN/A3.16%3.21%10.72%
P/E Ratio0.0011.6913.3125.30
Price / SalesN/A83.45261,614.66101.06
Price / CashN/A112.4557.5950.75
Price / BookN/A4.935.086.33
Net Income-$14.45M$766.88M$831.83M$347.70M

Yield10 Bioscience Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YTEN
Yield10 Bioscience
N/AN/AN/AN/A$257K$60KN/A30
ORIS
Oriental Rise
N/A$1.83
flat		N/AN/A$503K$12.22MN/AN/A
EDBL
Edible Garden
2.9695 of 5 stars		$1.67
-2.3%		$45.00
+2,594.6%		-99.8%$202K$13.43MN/A50
AAGRW
African Agriculture
N/AN/AN/AN/A$0.00$1.75MN/A85
CHSCP
CHS
N/A$26.64
+0.1%		N/A-7.2%$0.00$35.46BN/A10,683

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:YTEN) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Leading AI Insider Issues Urgent Market Warning
A leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...
TradeSmith | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Huge AI Announcement Coming on September 3
A $51 billion backlog, a SpaceX partnership, and a presidential endorsement are fueling renewed attention on t...
InvestorPlace | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel